“We welcome the opportunity to collaborate with Dr. Greten in the development of this promising combination therapy,” said Eun Sang Moon, chief executive officer of SillaJen. Dr. Greten is Senior Investigator in the Thoracic and Gastrointestinal Oncology Branch of NCI’s Center for Cancer research and an expert in GI Oncology and tumor immunology.  Dr. Greten […]

The post Sillajen Announces Collaboration with the National Cancer Institute for Development of Combination appeared first on STL News.